UA97812C2 - Прививочные макромолекулярные конъюгаты доксорубицина с противоопухолевой активностью и способ их получения - Google Patents

Прививочные макромолекулярные конъюгаты доксорубицина с противоопухолевой активностью и способ их получения

Info

Publication number
UA97812C2
UA97812C2 UAA200903818A UAA200903818A UA97812C2 UA 97812 C2 UA97812 C2 UA 97812C2 UA A200903818 A UAA200903818 A UA A200903818A UA A200903818 A UAA200903818 A UA A200903818A UA 97812 C2 UA97812 C2 UA 97812C2
Authority
UA
Ukraine
Prior art keywords
cancerostatic
connected via
polymeric drug
via spacers
hydroxypropyl
Prior art date
Application number
UAA200903818A
Other languages
English (en)
Ukrainian (uk)
Inventor
Томас Этрих
Петр Хитил
Карел Ульбрих
Томаш Мркван
Бланка Ригова
Original Assignee
Зэнтива, К.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Зэнтива, К.С. filed Critical Зэнтива, К.С.
Publication of UA97812C2 publication Critical patent/UA97812C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

Полимерное лекарственное средство, в котором канцеростатик, связан при помощи спейсеров, содержащих гидролитически расщепляющие гидразоновые связи, связан с водорастворимым полимерным носителем, полученным на основе сополимера N-(2-гидроксипропил)метакриламида, при этом структура полимерного лекарственного средства состоит из главной цепи N-(2-гидроксипропил)метакриламида, которая несет канцеростатик, и другой цепи N-(2-гидроксипропил)метакриламида - привитой цепи, которая также может нести канцеростатик, при этом указанные привитые цепи связаны с главной цепью связью, которая стабильна в организме, и/или связью, расщепляющей в организме, в частности олигопептидным спейсером, выбранным из группы GlyLeuGly, GlyPheGly, GlyPheLeuGly и GlyLeuPheGly, и способ его получения.
UAA200903818A 2006-09-18 2007-09-18 Прививочные макромолекулярные конъюгаты доксорубицина с противоопухолевой активностью и способ их получения UA97812C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20060592A CZ298945B6 (cs) 2006-09-18 2006-09-18 Polymerní lécivo a zpusob jeho výroby
PCT/CZ2007/000087 WO2008034391A1 (en) 2006-09-18 2007-09-18 Grafted macromolecular conjugates of doxorubicin with anticancer activity and method of their preparation

Publications (1)

Publication Number Publication Date
UA97812C2 true UA97812C2 (ru) 2012-03-26

Family

ID=38982478

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200903818A UA97812C2 (ru) 2006-09-18 2007-09-18 Прививочные макромолекулярные конъюгаты доксорубицина с противоопухолевой активностью и способ их получения

Country Status (6)

Country Link
US (1) US8603990B2 (ru)
EP (1) EP2063914B1 (ru)
CZ (1) CZ298945B6 (ru)
EA (1) EA017073B1 (ru)
UA (1) UA97812C2 (ru)
WO (1) WO2008034391A1 (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2739757C (en) 2008-10-07 2016-07-05 Rexahn Pharmaceuticals, Inc. Hpma - docetaxel or gemcitabine conjugates and uses therefore
CZ2008661A3 (cs) * 2008-10-23 2009-12-30 Zentiva, A. S Polymerní prípravek se synergickým úcinkem pri lécbe nádorových onemocnení
CZ303072B6 (cs) * 2009-02-13 2012-03-21 Zentiva, K.S. Polymerní konjugáty paclitaxelu a docetaxelu s pH rízeným uvolnováním kancerostatika
BR112012008772A2 (pt) 2009-10-13 2017-06-20 Rexahn Pharmaceuticals Inc sistemas poliméricos para a liberação de agentes anti-câncer
CZ302830B6 (cs) * 2009-12-15 2011-11-30 Ústav makromolekulární chemie AV CR, v.v.i. Vysokomolekulární polymerní nosice léciv odvozené od dendrimeru a jejich konjugáty s lécivy pro lécbu zejména pevných nádoru
DK2683393T3 (en) 2011-02-11 2018-07-23 Univ Michigan Regents TRIPEPTIME COMPOSITIONS AND THEIR USE IN TREATING DIABETES
HUE033575T2 (hu) 2011-05-26 2017-12-28 Xuanzhu Pharma Co Ltd Tirozin-kináz inhibitor kinazolin származék, elõállítási eljárása és alkalmazása
CN103936945B (zh) * 2013-01-23 2017-02-08 中国科学院化学研究所 一类高效抗肿瘤靶向药物载体及其制备方法
CN106995516B (zh) * 2016-01-22 2019-08-02 北京化工大学 肿瘤特异性富集的纳米载药体系及其制备方法
CZ308419B6 (cs) * 2016-04-11 2020-08-12 Ústav makromolekulární chemie AV ČR, v. v. i. Blokový kopolymer pro překonání lékové rezistence nádorů k chemoterapii, jeho polymerní konjugát s léčivem, farmaceutická kompozice je obsahující, způsob jejich přípravy a jejich použití
CN105963706B (zh) * 2016-04-15 2019-03-15 四川大学 一种支化hpma共聚物-dox偶联物及其制备方法和应用
CZ309585B6 (cs) * 2019-12-17 2023-05-03 Ústav makromolekulární chemie AV ČR, v. v. i. Polymerní konjugát s hydrolytickým uvolňováním kancerostatika cytarabinu, způsob jeho přípravy a jeho použití
CN112940248B (zh) * 2021-02-04 2023-07-18 西安交通大学 一种pH响应型金属配位聚前药纳米粒子及其制备方法
CN113908289B (zh) * 2021-10-09 2023-07-25 北京化工大学 一种具有精确调控药物比例的抗肿瘤多元载药体系及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE243501T1 (de) * 1993-11-18 2003-07-15 Sirtex Medical Ltd Zubereitung mit gesteuerter freisetzung
US6060518A (en) * 1996-08-16 2000-05-09 Supratek Pharma Inc. Polymer compositions for chemotherapy and methods of treatment using the same
GB9913359D0 (en) * 1999-06-09 1999-08-11 Cancer Res Campaign Tech Polymer modified biological elements
CZ293787B6 (cs) 2001-12-20 2004-07-14 Zentiva, A.S. pH senzitivní polymerní konjugáty antracyklinového kancerostatika pro cílenou terapii
CZ294996B6 (cs) * 2003-07-16 2005-04-13 Ústav Makromolekulární Chemie Av Čr Reaktivní polymery a kopolymery na bázi N-(2-hydroxypropyl)methakrylamidu, způsob jejich přípravy a jejich použití pro syntézu polymerních léčiv, pro modifikaci biologicky aktivních proteinů a přípravu systémů pro dopravu genů
CZ2005558A3 (cs) * 2005-09-05 2007-04-04 Zentiva, A. S. Zpusob prípravy polymerních konjugátu doxorubicinu s pH-rízeným uvolnováním léciva

Also Published As

Publication number Publication date
CZ2006592A3 (cs) 2008-03-19
WO2008034391A1 (en) 2008-03-27
US8603990B2 (en) 2013-12-10
EP2063914A1 (en) 2009-06-03
EA200900453A1 (ru) 2009-10-30
EP2063914B1 (en) 2018-12-26
CZ298945B6 (cs) 2008-03-19
US20090306004A1 (en) 2009-12-10
EA017073B1 (ru) 2012-09-28

Similar Documents

Publication Publication Date Title
UA97812C2 (ru) Прививочные макромолекулярные конъюгаты доксорубицина с противоопухолевой активностью и способ их получения
NO20065881L (no) Kjemiske bindinger og konjugater derav
CY1113206T1 (el) Μεθοδος παρασκευης προϊοντος συζευξης αντισωματος maytansinoid
WO2008006895A3 (en) Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta t cell activators
TW200621754A (en) Chemical compounds
TW200619217A (en) Chemical compounds
EP1781345A4 (en) IMMOBILIZATION OF CELLS IN A MATRIX OF BIOKOMPATIBLE LOADED POLYMERS UNDER LAMINAR FLOW CONDITIONS
TW200738711A (en) Chemical compounds
WO2004011611A3 (en) Taci antibodies and uses thereof
EA200702278A1 (ru) Антитела, специфичные в отношении tgf-бета 1
NO20092052L (no) Antistoffer og immunkonjugater, og anvendelser derav
MXPA06011924A (es) Dispositivo de liberacion continua base polimeros.
WO2006029219A3 (en) Human monoclonal anti-ctla4 antibodies in cancer treatment
EP1731550A4 (en) NEW WATER SOLUBLE FULLERING, MANUFACTURING METHOD AND ACTIVE OXYGEN GENERATOR WITH FULLERING
MY148763A (en) Anti-5t4 antibodies and uses thereof
UA95959C2 (en) Leptomycin derivatives
TW200606177A (en) Glycoprotein VI antibodies and methods thereof
WO2007008539A3 (en) Pyranopyridine compounds
EP2447282A3 (en) Anti-CD22 Antibodies, their Immunoconjugates and uses thereof
WO2008100346A3 (en) N-substituted monomers and polymers
EP1957038B8 (en) Particles
WO2006118884A3 (en) Drug delivery devices and related components, systems and methods
WO2008120998A3 (en) Acoustically sensitive drug delivery particles
WO2006076131A3 (en) Chemical compounds
WO2006020681A3 (en) Compounds and methods for the treatment of ubiquitin conjugating disorders